Product Information
CHILDREN IBUPROFEN 100 MG/5 ML is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.0338 per ML under NDC 45802013326. Its NADAC has been published 633 times since Jul 9, 2014.
FDA first approved this application on Dec 22, 1998.
Strength
100 mg/5mL
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802013326
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA074937FDA Approved
12/22/1998
On Market Since
4/9/2014
Pharmacological Classes
Price Statistics
The NADAC for CHILDREN IBUPROFEN 100 MG/5 ML has been published 633 times since Jul 9, 2014, and over the history we have for it it has risen 29.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0338 per ML |
|---|---|
| All-time high | $0.0394 (Dec 13, 2023) |
| All-time low | $0.0236 (Jan 19, 2022) |
| 52-week high | $0.0358 |
| 52-week low | $0.0338 |
| Median price | $0.0286 |
| Average price | $0.0302 |
| Largest weekly change | +42.7% (Mar 22, 2023) |
| Weeks tracked | 633 |
| Tracking since | Jul 9, 2014 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CHILDREN IBUPROFEN 100 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for CHILDREN IBUPROFEN 100 MG/5 ML, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.0338 per ML (NDC 45802013326), effective Aug 19, 2026.
How has the price of CHILDREN IBUPROFEN 100 MG/5 ML changed over time?
Over the history we have for it, the NADAC for CHILDREN IBUPROFEN 100 MG/5 ML has risen 29.0%. It has been tracked across 633 weekly CMS publications since Jul 9, 2014.
What are the highest and lowest recorded NADAC prices for CHILDREN IBUPROFEN 100 MG/5 ML?
Since Jul 9, 2014, the NADAC for CHILDREN IBUPROFEN 100 MG/5 ML has ranged from a low of $0.0236 (Jan 19, 2022) to a high of $0.0394 (Dec 13, 2023), with a median of $0.0286 per ML.
Are there cheaper alternatives to CHILDREN IBUPROFEN 100 MG/5 ML?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 100 MG/5 ML SUSP, is $0.0239 per ML — about 29% below CHILDREN IBUPROFEN 100 MG/5 ML.
Who manufactures CHILDREN IBUPROFEN 100 MG/5 ML?
CHILDREN IBUPROFEN 100 MG/5 ML (NDC 45802013326) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.